CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype.
Saved in:
| Title: | CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype. |
|---|---|
| Authors: | de Zélicourt A; Université Paris-Saclay, UVSQ, Inserm, END-ICAP, Versailles, France.; Institut des Neurosciences Paris-Saclay, CNRS, Université Paris-Saclay, Saclay, France., Fayssoil A; Université Paris-Saclay, UVSQ, Inserm, END-ICAP, Versailles, France., Dakouane-Giudicelli M; Université Paris-Saclay, UVSQ, Inserm, END-ICAP, Versailles, France., De Jesus I; Université Paris-Saclay, UVSQ, Inserm, END-ICAP, Versailles, France., Karoui A; Signalisation et Physiopathologie Cardiovasculaire, INSERM, UMR-S 1180 - Université Paris-Saclay, Châtenay-Malabry, France., Zarrouki F; Université Paris-Saclay, UVSQ, Inserm, END-ICAP, Versailles, France., Lefebvre F; Signalisation et Physiopathologie Cardiovasculaire, INSERM, UMR-S 1180 - Université Paris-Saclay, Châtenay-Malabry, France., Mansart A; Université Paris-Saclay, UVSQ, Inserm, 2I, Versailles, France., Launay JM; Service de Biochimie, INSERM UMR S942, Hôpital Lariboisière, Paris, France., Piquereau J; Signalisation et Physiopathologie Cardiovasculaire, INSERM, UMR-S 1180 - Université Paris-Saclay, Châtenay-Malabry, France., Tarragó MG; Department of Anesthesiology and Kogod Aging Center, Mayo Clinic, Rochester, Minnesota, USA., Bonay M; Université Paris-Saclay, UVSQ, Inserm, END-ICAP, Versailles, France., Forand A; Centre de Recherche en Myologie, Faculté de Médecine de la Pitié Salpêtrière, Sorbonne Université-UMRS974-Inserm-Institut de Myologie, Paris, France.; Inovarion, Paris, France., Moog S; Centre de Recherche en Myologie, Faculté de Médecine de la Pitié Salpêtrière, Sorbonne Université-UMRS974-Inserm-Institut de Myologie, Paris, France.; Inovarion, Paris, France., Piétri-Rouxel F; Centre de Recherche en Myologie, Faculté de Médecine de la Pitié Salpêtrière, Sorbonne Université-UMRS974-Inserm-Institut de Myologie, Paris, France., Brisebard E; INRAE Oniris UMR0703, APEX, Nantes, France., Chini CCS; Department of Anesthesiology and Kogod Aging Center, Mayo Clinic, Rochester, Minnesota, USA., Kashyap S; Department of Anesthesiology and Kogod Aging Center, Mayo Clinic, Rochester, Minnesota, USA., Fogarty MJ; Department of Anesthesiology and Kogod Aging Center, Mayo Clinic, Rochester, Minnesota, USA., Sieck GC; Department of Anesthesiology and Kogod Aging Center, Mayo Clinic, Rochester, Minnesota, USA., Mericskay M; Signalisation et Physiopathologie Cardiovasculaire, INSERM, UMR-S 1180 - Université Paris-Saclay, Châtenay-Malabry, France., Chini EN; Department of Anesthesiology and Kogod Aging Center, Mayo Clinic, Rochester, Minnesota, USA., Gomez AM; Signalisation et Physiopathologie Cardiovasculaire, INSERM, UMR-S 1180 - Université Paris-Saclay, Châtenay-Malabry, France., Cancela JM; Institut des Neurosciences Paris-Saclay, CNRS, Université Paris-Saclay, Saclay, France., de la Porte S; Université Paris-Saclay, UVSQ, Inserm, END-ICAP, Versailles, France. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2022 May 09; Vol. 14 (5), pp. e12860. Date of Electronic Publication: 2022 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1757-4684 |
|---|---|
| DOI: | 10.15252/emmm.202012860 |
